Clinical application of the ultrasound small probe in patients with peripheral lung cancer
Objective:To explore the clinical application of the ultrasound microprobe in patients with peripheral lung cancer.Methods:A study was conducted on 83 patients with peripheral lung cancer admitted to Shenzhen Hospi-tal,University of Chinese Academy of Sciences from January 2021 to December 2022.All patients underwent small probe ultrasound examination.Based on the pathological results as the gold standard,the patients were divided into metastatic and non metastatic groups according to the presence or absence of lymph node metastasis.The ultrasound parameters,MCVD,and MVD in the two groups were compared,and the correlation between MCVD and MVD was analyzed.The severity of the condition was evaluated based on TNM staging,and the MCVD and MVD of each group of patients were compared,and the correlation between MCVD and TNM staging was analyzed.Results:The proportion of patients with low echo,uneven echo,clear boundary,and short diameter≥1.0 cm in the metastatic group was 75.00%,85.71%,78.57%,and 71.43%,respectively,higher than 29.09%,40.00%,49.09%,and 38.18%in the non metastatic group(P＜0.05).The levels of MCVD and MVD in the metastatic group were higher than those in the non metastatic group(P＜0.05).Pearson correlation analysis showed a positive correlation between MCVD and MVD(r=0.622,P＜0.05).The differences in MCVD and MVD among patients with different TNM stages were statistically significant,and they were all in stagesⅠ＜Ⅱ＜Ⅲ(P＜0.05).The correlation analysis results showed a positive correlation be-tween MCVD and TNM staging(r=0.817,P=0.013).Conclusion:The proportion of patients with peripheral lung cancer who have lymph node metastasis is low echo,uneven echo,clear boundary,short diameter≥1.0 cm were high-er.Small probe ultrasound MCVD is positively correlated with MVD and TNM staging.
Peripheral lung cancerSmall probe ultrasoundThe severity of the conditionrelevance
NETL
NSTL
万方数据
维普
